Subtleties of Structure-Agonist Versus Antagonist Relationships of Opioid Peptides and Peptidomimetics
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in Journal of Receptors and Signal Transduction
- Vol. 19 (1-4) , 573-588
- https://doi.org/10.3109/10799899909036673
Abstract
The development of novel δ opioid antagonists and δ opioid agonists structurally derived from the prototype δ antagonist TIPP (H-Tyr-Tic-Phe-Phe-OH), is reviewed. Both δ antagonists and δ agonists with extraordinary potency and unprecedented δ receptor selectivity were discovered. Some of them are already widely used as pharmacological tools and are also of interest as potential therapeutic agents for use in analgesia. The results of the performed structure-activity studies revealed that the δ antagonist versus δ agonist behavior of this class of compounds depended on very subtle structural differences in diverse locations of the molecule. These observations can be best explained with a receptor model involving a number of different inactive and active receptor conformations.Keywords
This publication has 25 references indexed in Scilit:
- TIPP[.psi.]: a highly potent and stable pseudopeptide .delta. opioid receptor antagonist with extraordinary .delta. selectivityJournal of Medicinal Chemistry, 1993
- Spontaneous degradation via diketopiperazine formation of peptides containing a tetrahydroisoquinoline‐3‐carboxylic acid residue in the 2‐position of the peptide sequenceInternational Journal of Peptide and Protein Research, 1993
- Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.Proceedings of the National Academy of Sciences, 1992
- N,N-diallyl-tyrosyl substitution confers antagonist properties on the κ-selective opioid peptide [D-Pro10]dynorphin A(1-11)British Journal of Pharmacology, 1988
- Design and synthesis of somatostatin analogs with topographical properties that lead to highly potent and specific .mu. opioid receptor antagonists with greatly reduced binding at somatostatin receptorsJournal of Medicinal Chemistry, 1988
- Application of the message-address concept in the design of highly potent and selective non-peptide .delta. opioid receptor antagonistsJournal of Medicinal Chemistry, 1988
- Binaltorphimine and nor-binaltorphimine, potent and selective k-opioid receptor antagonistsLife Sciences, 1987
- Selectivities of opioid peptide analogues as agonists and antagonists at the δ‐receptorBritish Journal of Pharmacology, 1984
- Selective antagonists at the opiate delta-receptorLife Sciences, 1982
- Opiate antagonistic properties of an octapeptide somatostatin analog.Proceedings of the National Academy of Sciences, 1982